Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.49 |
| ▸ | SLC16A3 | O15427 | 3/20 | 0.48 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.47 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.47 |
| ▸ | BID | P55957 | 3/20 | 0.45 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.45 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.45 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.45 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.45 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.45 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.45 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.45 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.45 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.45 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.45 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29581945 | 1.00 | POLB (0.53) | POLBLIPGSLC16A3CYSLTR2CYSLTR1 | |
| SCHEMBL29581258 | 0.98 | LIPG (0.51) | POLBLIPGSLC16A3CYSLTR2CYSLTR1 | |
| SCHEMBL29581079 | 0.98 | LIPG (0.51) | POLBLIPGSLC16A3CYSLTR2CYSLTR1 | |
| SCHEMBL28938813 | 0.98 | LIPG (0.51) | POLBLIPGSLC16A3CYSLTR2CYSLTR1 | |
| SCHEMBL29580679 | 0.98 | LIPG (0.51) | POLBLIPGSLC16A3CYSLTR2CYSLTR1 | |
| SCHEMBL1955161 | 0.98 | LIPG (0.51) | POLBLIPGSLC16A3CYSLTR2CYSLTR1 | |
| SCHEMBL28938797 | 0.98 | LIPG (0.51) | POLBLIPGSLC16A3CYSLTR2CYSLTR1 | |
| SCHEMBL29580702 | 0.98 | LIPG (0.51) | POLBLIPGSLC16A3CYSLTR2CYSLTR1 | |
| SCHEMBL1953695 | 0.98 | LIPG (0.51) | POLBLIPGSLC16A3CYSLTR2CYSLTR1 | |
| SCHEMBL28673236 | 0.98 | LIPG (0.51) | POLBLIPGSLC16A3CYSLTR2CYSLTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3527600-B1 | ISOCYANATE COMPOSITION AND PRODUCTION METHOD FOR ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-09 | — | — | EP | disclosed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-04-13 | — | — | US | disclosed |
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-01-10 | — | — | US | disclosed |
| EP-3838892-B1 | METHOD FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2022-10-12 | — | — | EP | disclosed |
| CN-109803992-B | Isocyanate composition and method for producing isocyanate polymer | 旭化成株式会社 | 2022-05-24 | — | — | CN | disclosed |
| CN-109843963-B | Isocyanate composition, method for producing isocyanate polymer, and isocyanate polymer | 旭化成株式会社 | 2022-05-13 | — | — | CN | disclosed |
| EP-3536683-B1 | POLYISOCYANATE COMPOSITION AND ISOCYANATE POLYMER COMPOSITION | ASAHI CHEMICAL IND (JP) | 2021-11-24 | — | — | EP | disclosed |
| US-11174337-B2 | Isocyanate composition, method for producing isocyanate polymer and isocyanate polymer | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-11-16 | — | — | US | disclosed |
| CN-107963982-B | Polyisocyanate composition and isocyanate polymer composition | 旭化成株式会社 | 2021-11-12 | — | — | CN | disclosed |
| CN-1434796-A | Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals | AVENTIS PHARMA GMBH | 2003-08-06 | — | — | CN | disclosed |
| CN-1434796-A | Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals | AVENTIS PHARMA GMBH | 2003-08-06 | — | — | CN | disclosed |
| EP-1294682-A1 | ACYLPHENYL UREA DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND USE THEREOF AS A MEDICAMENT | Aventis Pharma Deutschland GmbH (DE) | 2003-03-26 | — | — | EP | disclosed |
| US-6506778-B2 | Antidiabetic agents | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-01-14 | — | — | US | disclosed |
| US-6506778-B2 | Antidiabetic agents | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-01-14 | — | — | US | disclosed |
| US-6506778-B2 | Antidiabetic agents | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-01-14 | — | — | US | disclosed |
| US-20020151586-A1 | Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2002-10-17 | — | — | US | disclosed |
| US-20020151586-A1 | Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2002-10-17 | — | — | US | disclosed |
| US-20020151586-A1 | Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2002-10-17 | — | — | US | disclosed |
| WO-2001094300-A1 | ACYLPHENYL UREA DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND USE THEREOF AS A MEDICAMENT | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-12-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | IDH3A, IDH2, IDH3B | POLB 3507/4885LIPG 4704/4885SLC16A3 918/4885 |
| US-20020151586-A1 | Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals | ACAD11, CYP4F11, CYP4A11 | POLB 1822/4885LIPG 1961/4885SLC16A3 590/4885 |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | IDH3A, IDH2, IDH3B | POLB 3251/4885LIPG 4697/4885SLC16A3 1156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.